InMode Ltd (INMD)
18.01
-0.99
(-5.21%)
USD |
NASDAQ |
Nov 15, 16:00
17.96
-0.05
(-0.28%)
After-Hours: 04:52
InMode Gross Profit Margin (Quarterly): 81.53% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 81.53% |
June 30, 2024 | 80.20% |
March 31, 2024 | 79.62% |
December 31, 2023 | 84.02% |
September 30, 2023 | 83.64% |
June 30, 2023 | 83.79% |
March 31, 2023 | 82.79% |
December 31, 2022 | 84.28% |
September 30, 2022 | 84.52% |
June 30, 2022 | 83.31% |
March 31, 2022 | 82.81% |
December 31, 2021 | 84.76% |
September 30, 2021 | 85.19% |
June 30, 2021 | 85.43% |
Date | Value |
---|---|
March 31, 2021 | 84.62% |
December 31, 2020 | 85.94% |
September 30, 2020 | 84.27% |
June 30, 2020 | 84.74% |
March 31, 2020 | 84.71% |
December 31, 2019 | 87.14% |
September 30, 2019 | 87.39% |
June 30, 2019 | 87.43% |
March 31, 2019 | 86.02% |
December 31, 2018 | 86.31% |
September 30, 2018 | 85.57% |
June 30, 2018 | 84.36% |
March 31, 2018 | 83.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
79.62%
Minimum
Mar 2024
87.14%
Maximum
Dec 2019
83.87%
Average
84.27%
Median
Gross Profit Margin (Quarterly) Benchmarks
Compugen Ltd | 78.98% |
Pluri Inc | -- |
BioLine Rx Ltd | 83.37% |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 20.14% |
Return on Assets | 18.15% |
Return on Invested Capital | 20.14% |
Profit Margin (Quarterly) | 39.15% |
Operating Margin (Quarterly) | 37.06% |
Return on Net Operating Assets | 127.6% |